Masonic Cancer Center, University Of Minnesota
Clinical trials sponsored by Masonic Cancer Center, University Of Minnesota, explained in plain language.
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Could gut bugs boost cancer drug power? new trial investigates
Disease control Recruiting nowThis study is testing whether adding a special gut bacteria supplement (called restorative microbiota therapy) to standard chemotherapy and immunotherapy drugs helps people with advanced lung cancer live longer without their cancer getting worse. About 82 participants will be ran…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New transplant approach aims to control lymphoma without radiation
Disease control Recruiting nowThis study is testing a stem cell transplant procedure that does not use radiation to prepare the body. It aims to control Hodgkin and non-Hodgkin lymphoma in patients whose cancer has returned or is hard to treat, including people living with HIV. Researchers will compare how lo…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Second chance: new treatment aims to rescue failed bone marrow transplants
Disease control Recruiting nowThis trial is testing a treatment for patients whose first bone marrow or stem cell transplant failed. The goal is to help a second transplant from a partially matched family donor successfully take hold and grow. The treatment uses a combination of chemotherapy and low-dose radi…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Experimental cell therapy targets hard-to-treat ovarian cancers
Disease control Recruiting nowThis early-stage trial is testing whether a modified immune cell therapy called FT536 can help control recurrent ovarian, fallopian tube, or primary peritoneal cancers. Participants receive chemotherapy followed by FT536 delivered directly into the abdomen through a temporary cat…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New transplant trial aims to free patients from lifelong blood transfusions
Disease control Recruiting nowThis study is testing a donor stem cell transplant to treat people with severe inherited blood disorders like sickle cell disease and thalassemia, who currently depend on regular blood transfusions. The goal is to replace the patient's faulty blood-making system with a healthy do…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Double-Dose stem cell attack on deadly childhood cancer
Disease control Recruiting nowThis study is testing a two-part, high-dose chemotherapy treatment followed by two separate stem cell transplants for children and young adults with high-risk neuroblastoma. The goal is to better control the cancer and prevent it from coming back after initial treatment. Research…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New transplant method aims to reduce dangerous side effects for rare blood disorders
Disease control Recruiting nowThis study is testing a modified stem cell transplant procedure for people with inherited bone marrow failure disorders like Fanconi anemia. The goal is to see if removing specific immune cells from the donor cells before transplant can reduce the risk of a serious complication c…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
First human test of Lab-Grown muscle cells for devastating muscle disease
Disease control Recruiting nowThis early-stage study is testing whether lab-grown muscle stem cells are safe when injected into the foot muscles of adults with Duchenne muscular dystrophy (DMD). Researchers will give eight non-walking adults a single injection and monitor them closely for side effects. The ma…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test 'Alarm' injection to wake up immune system against tough cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a new experimental injection called Peptide Alarm Therapy (PAT) when given directly into tumors alongside standard immunotherapy. It's for adults with advanced solid tumors that have continued to grow despite one or more prior treat…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Doctors test virus that targets pancreatic tumors
Disease control Recruiting nowThis early-stage study is testing a modified virus designed to infect and destroy pancreatic cancer cells when injected directly into tumors. Researchers are looking for the highest safe dose in 18 patients whose cancer is still confined to the pancreas area. The virus is deliver…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC
-
Experimental cord blood treatment offers hope for blood cancer patients
Disease control Recruiting nowThis study tests the safety of using unlicensed cord blood units for patients with blood cancers who need stem cell transplants. Researchers want to make sure these cord blood units don't transmit infections or cause serious reactions during infusion. The trial will track 250 pat…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Free legal aid offered to ease burden on cancer caregivers
Symptom relief Recruiting nowThis study is testing whether connecting caregivers of colorectal cancer patients with free legal services can help reduce their stress and financial strain. The pilot program will provide personalized legal care to 20 patient-caregiver pairs for 3 months. Researchers will measur…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
New nerve block could offer safer pain relief after major abdominal surgery
Symptom relief Recruiting nowThis study is testing if a newer pain control method works as well as the current standard for patients having major pancreas surgery. The new method involves injecting long-lasting numbing medicine into the abdominal wall (a rectus sheath block), while the standard method uses a…
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Mar 03, 2026 14:06 UTC
-
Can your phone catch brain fog from cancer treatment?
Knowledge-focused Recruiting nowThis study is testing a new digital tool called SALSA to see if it can spot thinking and memory problems early in cancer patients receiving a powerful immunotherapy called CAR-T. Researchers will compare the tool to standard check-ups in about 38 adults getting CAR-T treatment in…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test fitness limits of young survivors
Knowledge-focused Recruiting nowThis study aims to understand why young survivors of leukemia, chronic lung disease from prematurity, and heart transplants often struggle with exercise. Researchers will measure heart and lung function during bike workouts in 90 participants aged 8-25. The goal is to gather data…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Does relighting your cigarette make it more toxic?
Knowledge-focused Recruiting nowThis study aims to understand if relighting a cigarette produces more harmful chemicals than smoking it without stopping. Researchers will observe 30 adult smokers who regularly relight cigarettes, measuring the smoke they produce and asking about their experience. The goal is to…
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Scientists track hidden dangers in Firefighters' bodies after blazes
Knowledge-focused Recruiting nowThis study aims to understand what harmful chemicals firefighters absorb when fighting building fires. Researchers will collect urine and cheek cell samples from 60 firefighters before a fire call, then again within 24 hours and one week after. By comparing these samples, they ho…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC